Wellgistics Health, Inc. 是一家以藥品和醫療服務為核心的控股公司。公司總部位於佛羅里達州坦帕。該公司在2025年2月21日上市。公司專注於專業藥品和以社區為基礎的模式,為患者提供送藥到家的服務。公司致力於在為藥房、醫療機構、製藥廠和保險支付方提供解決方案的同時,改善患者的生活品質。其技術平台DelivMeds作為一個藥房中心,使臨床服務能夠與公司的健康藥房運營相連接。該平台將提供一個端到端的移動應用程式解決方案,讓患者能夠數位化他們的處方流程。這一解決方案有助於保障患者的自主權、提高處方藥價格透明度,並提供額外的禮賓服務。其產品包括Kyzatrex、司美格魯肽(Semaglutide)和替爾泊肽(Tirzepatide)。
WGRX stock price ended at $0.13 on 星期三, after dropping 23.53%
On the latest trading day May 20, 2026, the stock price of WGRX fell by 23.53%, dropping from $0.22 to $0.13. During the session, the stock saw a volatility of 130.00%, with prices oscillating between a daily low of $0.10 and a high of $0.23. On the latest trading day, the trading volume for WGRX rose by 50.8M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 129.0M shares were traded, with a market value of approximately $16.5M.